Company Monitoring Page for Allergan

latest headlines for company on cafepharma

SEC hands Allergan a $15M speeding ticket for blowing off disclosure rules in a tough 2014 fight against Valeant
Endpoints
Tue, 01/17/17 - 10:12 pm
Tags:
SEC, Allergan, Valeant Pharmaceuticals, M&A, Actavis
Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
TheStreet.com
Wed, 01/11/17 - 10:04 am
Tags:
Allergan, Brent Saunders, Pharma CEOs, M&A, JPMHC 2017
Allergan CEO on the Hot Seat: Here's What He Had to Say
Motley Fool
Sat, 01/7/17 - 12:36 pm
Tags:
Allergan, Pharma CEOs, Brent Saunders
FDA accepts Allergan’s new drug application for Liletta contraception device
Mass Device
Wed, 01/4/17 - 10:47 am
Tags:
FDA, Allergan, Liletta, contraceptives, devices
What Was Wrong For Allergan In 2016 And Why 2017 Is Likely To Be Different
Seeking Alpha
Tue, 12/27/16 - 10:12 am
Tags:
Allergan
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Tags:
Ophthalmic Drugs Market, Ocular Therapeutix, Eylea, Restasis, Lucentis, Regeneron, Roche, Allergan
Allergan Is Losing Its No. 2 Product More Rapidly Than Expected
Seeking Alpha
Wed, 12/21/16 - 10:53 am
Tags:
Allergan, dry eye disease, Restasis, Shire, Xiidra
Allergan picks up regenerative med company for $2.9B
BioPharma Dive
Wed, 12/21/16 - 10:47 am
Tags:
Allergan, M&A, regenerative medicine, Acelity, devices
Allergan eyes depression as blockbuster Botox's next big stage
Fierce Pharma
Mon, 12/19/16 - 11:44 am
Tags:
Allergan, Botox, clinical depression
Could These 2 Small Biotechs Beat Allergan and Gilead Sciences?
Motley Fool
Sat, 12/17/16 - 12:23 pm
Tags:
biotech, Allergan, Gilead Sciences, Genfit, Intercept Pharmaceuticals, NASH
Allergan subsidiary settles kickback charges for $38M
BioPharma Dive
Sat, 12/17/16 - 12:12 pm
Tags:
Allergan, Forest Labs, kickbacks, False Claims Act, whistleblower lawsuits
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Tags:
Celgene, Darzalex, Multiple Myeloma, Allergan, generics, Abraxane, Revlimid
Mylan scores review of Allergan's Restasis IP, but analysts aren't worried about the med's fate
Fierce Pharma
Sun, 12/11/16 - 11:44 am
Tags:
Mylan Labs, Allergan, Restasis, patents, generics
Is the US biopharma industry headed for a turning point in 2017?
Endpoints
Tue, 12/6/16 - 10:43 pm
Tags:
drug pricing, Allergan, Novo Nordisk
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Mon, 12/5/16 - 09:59 am
Tags:
Amgen, Allergan, Avastin, biosimilars, Europe, ABP 215, non-squamous lung cancer
Pharma execs assess landscape under President Trump
Drug Delivery Business
Sat, 12/3/16 - 09:22 am
Tags:
Donald Trump, pharma industry, drug pricing, Regeneron, Allergan
Analyzing Allergan’s Growth Pharma Plans
Market Realist
Tue, 11/29/16 - 05:34 pm
Tags:
Allergan
Ex-Allergan prez Ingram forges $1B deal to sell Alzheimer’s biotech to Brent Saunders and the new crew at Allergan
Endpoints
Tue, 11/22/16 - 09:55 pm
Tags:
Allergan, Brent Saunders, Doug Ingram, Alzheimer's disease, Chase Pharmaceuticals
FDA clears Allergan’s Xen gel stent for glaucoma
Mass Device
Tue, 11/22/16 - 12:01 pm
Tags:
FDA, Allergan, Xen gel stent, glaucoma, devices, eye health
3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3
Motley Fool
Fri, 11/18/16 - 10:08 am
Tags:
Teva Pharmaceutical, Allergan, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.